Use of SNS-595 for treating leukemia

The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound t...

Full description

Saved in:
Bibliographic Details
Main Authors ADELMAN, Daniel, C, SATOSHI, Nakao, MASARU, Higaki, Silverman, Jeffrey A
Format Patent
LanguageEnglish
Hungarian
Published 28.10.2016
Subjects
BLASTING
HEATING
HUMAN NECESSITIES
HYGIENE
LIGHTING
MECHANICAL ENGINEERING
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RANGES
SOLAR HEAT COLLECTORS
SOLAR HEAT SYSTEMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
VENTILATING
WEAPONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides a compound for use in a method for treating a solid tumor in a patient, wherein the compound is (+)-1,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid and the method comprises administering the compound to the patient in a dose of 10 mg/m 2 to 100 mg/m 2 .
Bibliography:Application Number: HUE10177951